Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 4/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.35 |
| ▸ | ANPEP | P15144 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL554525 | 1.00 | KMT2A (0.42) | KMT2ALMNASMN1; SMN2POLBUSP2 | |
| SCHEMBL150432 | 0.85 | ALDH1A1 (0.44) | KMT2ALMNASMN1; SMN2POLBUSP2 | |
| SCHEMBL134537 | 0.85 | ALDH1A1 (0.44) | KMT2ALMNASMN1; SMN2POLBUSP2 | |
| Oxirane SCHEMBL1901298 | 0.82 | ALDH1A1 (0.42) | KMT2ALMNASMN1; SMN2POLBUSP2 | |
| SCHEMBL13518033 | 0.81 | KMT2A (0.40) | KMT2ALMNASMN1; SMN2POLBUSP2 | |
| SCHEMBL5057657 | 0.80 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL1534045 | 0.80 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL7700749 | 0.80 | ALDH1A1 (0.40) | KMT2ALMNAPOLBALDH1A1 | |
| Methacrylic Acid SCHEMBL9721014 | 0.80 | ALDH1A1 (0.40) | KMT2ALMNASMN1; SMN2POLBUSP2 | |
| SCHEMBL28005138 | 0.79 | HPGD (0.38) | KMT2ALMNASMN1; SMN2POLBUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260040695-A1 | A METHOD TO GENERATE CONDUCTIVE POLYMER | NEWSOUTH INNOVATIONS PTY LTD (AU) | 2026-02-05 | — | — | US | claimed |
| EP-4562077-A1 | A METHOD TO GENERATE CONDUCTIVE POLYMER | NewSouth Innovations Pty Limited (AU) | 2025-06-04 | — | — | EP | claimed |
| WO-2024020649-A1 | A METHOD TO GENERATE CONDUCTIVE POLYMER | NEWSOUTH INNOVATIONS PTY LIMITED (AU) | 2024-02-01 | — | — | WO | claimed |
| US-11773300-B2 | Acrylic adhesive compositions and methods of making same | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-10-03 | — | — | US | claimed |
| US-20230055665-A1 | DELIVERY CARRIER INTO CELL | ITO, KABUSIKIKAISYA (JP) | 2023-02-23 | — | — | US | claimed |
| WO-2022261721-A1 | HEALABLE AND REPROCESSABLE COMPOSITIONS | DEAKIN UNIVERSITY (AU) | 2022-12-22 | — | — | WO | claimed |
| US-20200255700-A1 | ACRYLIC ADHESIVE COMPOSITIONS AND METHODS OF MAKING SAME | DOW GLOBAL TECHNOLOGIES LLC | 2020-08-13 | — | — | US | claimed |
| EP-3688109-A1 | ACRYLIC ADHESIVE COMPOSITIONS AND METHODS OF MAKING SAME | Dow Global Technologies LLC (US) | 2020-08-05 | — | — | EP | claimed |
| WO-2019067070-A1 | ACRYLIC ADHESIVE COMPOSITIONS AND METHODS OF MAKING SAME | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-04-04 | — | — | WO | claimed |
| WO-2006101548-A2 | POSTPARTUM CELLS DERIVED FROM UMBILICAL CORD TISSUE, AND METHODS OF MAKING, CULTURING, AND USING THE SAME | ETHICON, INC. (US) | 2006-09-28 | — | — | WO | claimed |
| WO-2006083394-A2 | POSTPARTUM CELLS DERIVED FROM PLACENTAL TISSUE, AND METHODS OF MAKING, CULTURING, AND USING THE SAME | ETHICON, INC. (US) | 2006-08-10 | — | — | WO | claimed |
| US-20060166361-A1 | Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same | ETHICON, INC. | 2006-07-27 | — | — | US | claimed |
| US-5298554-A | Heating and solution polymerizing | BASF AKTIENGESELLSCHAFT (DE) | 1994-03-29 | — | — | US | claimed |
| US-12606699-B2 | Polymer composite, rubber composition, and tire | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2026-04-21 | — | — | US | disclosed |
| US-20260040695-A1 | A METHOD TO GENERATE CONDUCTIVE POLYMER | NEWSOUTH INNOVATIONS PTY LTD (AU) | 2026-02-05 | — | — | US | disclosed |
| EP-3668935-B1 | PRESSURE SENSITIVE ADHESIVE COMPOSITIONS AND METHODS OF MAKING SAME | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-12-24 | — | — | EP | disclosed |
| US-5298554-A | Heating and solution polymerizing | BASF AKTIENGESELLSCHAFT (DE) | 1994-03-29 | — | — | US | disclosed |
| EP-0463525-A1 | Polymers of olefinically unsaturated monomers and solutions of polymers of olefinically unsaturated monomers | BASF Aktiengesellschaft (DE) | 1992-01-02 | — | — | EP | disclosed |
| EP-0382214-A1 | Method of cell culture | KAO CORPORATION (JP) | 1990-08-16 | — | — | EP | disclosed |
| US-4822848-A | HOMOPOLYMERS OF N-TETRAHYDROFURFURYL ACRYLAMIDE OR N-TETRAHYDROFURFURYL METHACRYLAMIDE | AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY (JP) | 1989-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12606699-B2 | Polymer composite, rubber composition, and tire | ATR, PIP5K1A, CD40 | KMT2A 4446/4885LMNA 2610/4885SMN1; SMN2 202/4885 |
| US-20230055665-A1 | DELIVERY CARRIER INTO CELL | CTSA, ATG4A, ATG7 | KMT2A 4003/4885LMNA 1046/4885SMN1; SMN2 3062/4885 |
| US-20260040695-A1 | A METHOD TO GENERATE CONDUCTIVE POLYMER | PIEZO1, LCP1, MTCL3 | KMT2A 2492/4885LMNA 1730/4885SMN1; SMN2 531/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.